Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Osteogenesis Imperfecta | Kisho | Kisho

Back to Osteogenesis Imperfecta

Osteogenesis Imperfecta — NIH Grants & Funding

Active and recent NIH-funded research on Osteogenesis Imperfecta. Data from NIH RePORTER, last 36 months.

MONDO:0019019

NIH-funded research on Osteogenesis Imperfecta

active grants

institutions

researchers

new in last 12 mo.

$12.1M in NIH funding over the last 36 months. Data from NIH RePORTER.

I'm looking for:

Or filter by research focus

Only show active grants

Basic Science(14)

Basic ScienceZIACompleted

Genetic Disorders of Bone and Extracellular Matrix

Marini, Joan·EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT

$687,701 (FY2023)

Osteogenesis Imperfecta — NIH Grants & Funding

Basic Science(14)

Genetic Disorders of Bone and Extracellular Matrix

Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta

WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues

Heritable Disorders of Connective Tissue

Lung developmental defects caused by type I collagen mutations in mouse models of osteogenesis imperfecta

Mechanism of growth deficiency in dominant forms of osteogenesis imperfecta

Imaging structural and functional relationships between cells and ECM

Osteogenesis imperfecta caused by TMEM38B mutation: a deep investigation of cellular and extracellular consequences to identify new therapeutic targets

Genetic determinants of endoplasmic reticulum stress in OI and its consequences on cellular receptors

Mechanistic investigation into Frizzled-2 signaling for treatment of Osteogenesis Imperfecta

Translational(3)

Preclinical Testing of Early Life Anti-Myostatin Therapy for Osteogenesis

Targeting TGFb In Osteogenesis Imperfecta

Preclinical testing of early life anti-myostatin therapy for osteogenesis imperfecta

Epi / Nat. History(1)

Investigating pulmonary complications due to abnormal collagen/ER stress in Osteogenesis Imperfecta

Gene/Cell Therapy(3)

Development of a long-lasting, bone-targeted gene therapy for osteogenesis imperfecta

Cellular Therapy for Osteogenesis Imperfecta

Precision Gene Editing on Osteogenesis Imperfecta

Biomarker / Dx(1)

Biomarking the Sclerostin Antibody Effects on Osseointegration in an Osteogenesis Imperfecta Model